May 18, 2026
The smart healthcare market is expected to rise from USD 397.98 billion in 2026 to USD 1833.7 billion by 2035,...
Read MoreJanuary 19, 2026
The anti-aging market size is forecast to grow from USD 84.41 billion in 2026 to USD 137.13 billion by 2035, g...
Read MoreApril 21, 2026
The blood pressure measuring devices market is expected to see growth from USD 2.08 billion in 2026 to USD 4.5...
Read MoreJanuary 21, 2026
The medical device CMO and CDMO market is expected to see growth from USD 52.57 billion in 2026 to USD 110.82 ...
Read MoreApril 21, 2026
Projections indicate that, the global diabetes medicines market will increase from USD 109.38 billion in 2024 to USD 326.37 billion by 2034, experiencing a CAGR of 11.24% over the next 10 years. The diabetes medicines market is expanding due to an unhealthy lifestyle as well as the rising adoption of combination therapies. North America led the mar...
April 21, 2026
Projections indicate that, the global aflibercept biosimilars market will increase from USD 1.54 billion in 2024 to USD 3.7 billion by 2034, experiencing a CAGR of 9.14% over the next 10 years. The maturing ophthalmic biosimilar ecosystem is estimated to drive the growth of the market in the near future. The national health systems and tender-based...
April 21, 2026
According to market projections, the global insulin drugs and delivery devices market, valued at USD 23.75 billion in 2024, is anticipated to reach USD 49.18 billion by 2034, growing at a CAGR of 7.65% over the next decade. The rising prevalence of diabetes and growing research and development activities bolster market growth. North America led the...
April 21, 2026
Market insights predict, the compound management industry is expected to grow from USD 492.14 million in 2024 to USD 1899.41 million by 2034, driven by a CAGR of 14.51%. The compound management market is expanding due to growing outsourcing trends, as well as increasing clinical trials. North America led the market due to the presence of huge...
April 21, 2026
Based on market forecasts, the U.S. Controlled Substance market, projected at USD 52.3 billion in 2024, is expected to reach USD 84.95 billion by 2034, growing at a CAGR of 5.24% over the forecast period. The U.S. Controlled Substance Market is growing because these substances extend throughout manufacture, use, handling, distribution, and storage....
April 21, 2026
According to market projections, the global albumin pharma market, valued at USD 6.77 billion in 2024, is anticipated to reach USD 11.72 billion by 2034, growing at a CAGR of 5.65% over the next decade. The rising prevalence of chronic diseases such as liver cirrhosis, kidney disorders, and cardiovascular conditions increases demand for albumin-bas...
April 21, 2026
Projections indicate that, the global pharmaceutical stability & storage services market will increase from USD 3.4 billion in 2024 to USD 5.92 billion by 2034, experiencing a CAGR of 5.7% over the next 10 years. The compliance with global standards and the effectiveness of scientific quality assurance raise the importance of pharmaceuticals. N...
April 21, 2026
According to market projections, the oncology drugs sector is expected to grow from USD 204.39 billion in 2024 to USD 360.79 billion by 2034, reflecting a CAGR of 6.29%. The oncology drugs market is growing due to the increasing incidence of cancer, as poor lifestyle, longer working period, progressively stressful lives, alcohol consumption, smokin...
April 21, 2026
Market insights predict the global cancer supportive care drugs industry will increase from USD 21.89 billion in 2024 to USD 27.05 billion by 2034, achieving a CAGR of 2.14%. The increased focus on the prevention and management of the adverse effects of cancer medications and treatments fuels the demand for cancer supportive care drugs. North Ameri...
April 21, 2026
According to forecasts, the global cardiovascular drugs market will grow from USD 150.02 billion in 2024 to USD 213.36 billion by 2034, with an expected CAGR of 3.65%. The cardiovascular drugs market is expanding due to growing early diagnosis as well as lipid-lowering drug innovations. North America led the market due to the high healthcare invest...
+1 804 441 9344
+61 4859 81310 or +91 87933 22019
